Innovations

As a specialist in urology, APOGEPHA focuses on the research, development and improvement of therapies for urological diseases.

Research and development at APOGEPHA

Each year, APOGEPHA invests a significant proportion of its turnover in the research and development of new products and services.

Our focus is on the area of pharmaceutical development (development of new dosage forms and new medication forms) as well as on clinical development. APOGEPHA also relies on scientific cooperation with universities, clinics and companies.

Transformation from pharmaceutical manufacturer to healthcare company

As a partner in urology, APOGEPHA develops new and innovative solutions for the diagnosis and treatment of urological diseases. In the process, the patient and their treating therapist are the main focus of our considerations. Not just medication but also improved diagnostics, digital applications to support doctors and patients in their daily work and systems to better connect therapists and patients play a role here. This means that questions for the doctor and important information about the therapy can be exchanged immediately.

New products

APOGEPHA is constantly expanding its urological product portfolio in order to provide doctors and patients with the best options for treating urological diseases. The products are developed in-house - sometimes in collaboration with other companies or universities - or in-licensed. We also evaluate the purchase of products and product groups.

Healthcare research

APOGEPHA participates in studies on various urological indications in order to further improve treatment in daily practice. We are currently supporting healthcare research by D-UO in the form of research grants in the field of uro-oncology.